Yahoo Web Search

  1. Ads
    related to macular degeneration
  1. Yahoo Finance Results

  2. Ophthotech's (OPHT) Q1 Loss Narrows Y/Y, Zimura in Focus

    Zacks via Yahoo FinanceMay 10 14:41 PM

    Ophthotech Corporation OPHT reported a loss of 36 cents per share for the first quarter of 2018, narrower than a loss of $1.20 in the year-ago quarter. With no approved products in its portfolio ...

  3. "Mad Money" host Jim Cramer examines "the four horsemen of biotech" to see if their weakening stocks can regain momentum. With a major market comeback underway, CNBC's Jim Cramer zeroed in on ...

  4. 5 Steps to Lower Your Risk of Eye Disease

    PR Newswire via Yahoo FinanceMay 08 1:07 AM

    Four eye diseases — age-related macular degeneration (AMD), diabetic retinopathy, glaucoma and cataracts — account for most cases of adult blindness and low vision among people ...

  5. FDA seeks permanent injunctions against two stem cell clinics

    PR Newswire via Yahoo FinanceMay 09 21:52 PM

    SILVER SPRING, Md., May 9, 2018 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration, in two complaints filed today in federal court, is seeking permanent injunctions to stop two ...

  6. Edited Transcript of EYEN.OQ earnings conference call or presentation 9-May-18 12:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceMay 11 13:21 PM

    We also recently completed an additional clinical trial, the Eyenovia PG21, which demonstrated the robust IOP, intraocular pressure lowering effect of our high-precision piezo-print micro-dosing ...

  7. Edited Transcript of REGN earnings conference call or presentation 3-May-18 12:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceMay 08 20:15 PM

    Top line data from the Phase III nasal polyps study and the adolescent atopic dermatitis study are expected later this year. In addition, in the second half of this year, we plan to begin pivotal ...

  8. NASDAQ: ARQL) BioLife Solutions Inc (NASDAQ: BLFS) Crispr Therapeutics AG (NASDAQ: CRSP) CTI BioPharma Corp (NASDAQ: CTIC) Cytosorbents Corp (NASDAQ: CTSO) Eiger Biopharmaceuticals Inc (NASDAQ ...

  9. Edited Transcript of OPHT earnings conference call or presentation 9-May-18 12:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceMay 16 3:52 AM

    Gene Therapy Center and continue to build on our Zimura complement factor C5 inhibitor program, with ongoing clinical trials in multiple ophthalmic diseases: first, our Phase IIa trial in wet ...

  10. Edited Transcript of BTX earnings conference call or presentation 10-May-18 8:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceMay 17 1:53 AM

    The positive OpRegen data presented was from the first 9 patients in the first 3 cohorts for this Phase I/IIa clinical trial. There were no serious adverse events noted. And importantly, the ...

  11. Edited Transcript of RGNX earnings conference call or presentation 8-May-18 8:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceMay 15 20:12 PM

    So in summary, we've had a productive first quarter as we've continued to see meaningful advancement of our internal and externally partnered product candidates while progressing towards the ...

  1. Ads
    related to macular degeneration